Affiliation: Virginia Mason Medical Center
- Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancerDonald E Low
Thoracic Oncology Program and Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA 98111, USA
J Gastrointest Surg 11:1395-402; discussion 1402. 2007....
- Invited commentaryDonald E Low
Thoracic Surgery and Thoracic Oncology, Virginia Mason Medical Center, Seattle, WA 98111, USA
Ann Thorac Surg 86:1138. 2008
- Update on clinical impact, documentation, and management of complications associated with esophagectomyDonald E Low
Department of Thoracic Surgery and Thoracic Oncology, Virginia Mason Medical Center, 1100 Ninth Avenue, Seattle, WA 98111, USA Electronic address
Thorac Surg Clin 23:535-50. 2013..New endoscopic and interventional approaches to treating anastomotic leak and stricture and chyle leak can selectively decrease length of stay and costs of managing complications. ..
- Evolution in surgical management of esophageal cancerDonald E Low
Department of Thoracic Surgery and Thoracic Oncology, Virginia Mason Medical Center, Seattle, WA 98111, USA
Dig Dis 31:21-9. 2013....
- Open repair of paraesophageal hernia: reassessment of subjective and objective outcomesDonald E Low
Section of General Thoracic Surgery, Virginia Mason Medical Center, Seattle, Washington 98111, USA
Ann Thorac Surg 80:287-94. 2005..Increasing numbers of patients are undergoing laparoscopic repair. This series provides an up-to-date benchmark of the results of open repair of PEH to compare with current laparoscopic series...
- Invited commentaryDonald Low
Department of Surgery, Virginia Mason Medical Center, 1100 9th Ave, Seattle, WA 98111, USA
Ann Thorac Surg 84:231. 2007
- Invited commentaryDonald Low
General Thoracic Surgery, Virginia Mason Medical Center, 1100 Ninth Ave, Seattle, WA 98111, USA
Ann Thorac Surg 85:1952-3. 2008
- Open versus minimally invasive esophagectomy: what is the best approach? Frame the issueDonald E Low
Department of Thoracic Surgery and Thoracic Oncology, Virginia Mason Medical Center, Seattle, WA 98101, USA
J Gastrointest Surg 15:1497-9. 2011..In the absence of either randomized or controlled prospective comparisons, this series of papers will review current perceptions of the advantages of both minimally invasive and open surgery for the treatment of esophageal cancer...
- Evolution in perioperative management of patients undergoing oesophagectomyD E Low
Virginia Mason Medical Center, 1100 Ninth Avenue, Seattle, Washington 98111, USA
Br J Surg 94:655-6. 2007
- Useful benchmarks to evaluate outcomes after esophagectomy and pancreaticoduodenectomyL William Traverso
Department of General, Thoracic, and Vascular Surgery, Virginia Mason Medical Center, 1100 Ninth Ave, PO Box 900, Seattle, WA 98111 0900, USA
Am J Surg 187:604-8. 2004..If a low-volume center recorded high mortality, then a broader set of outcomes beyond mortality would be useful for self-assessment...
- Update on staging and surgical treatment options for esophageal cancerDonald E Low
Thoracic Surgery and Thoracic Oncology, C6 GS, Virginia Mason Medical Center, 1100 Ninth Ave, Seattle, WA 98101, USA
J Gastrointest Surg 15:719-29. 2011..The incidence of esophageal cancer is increasing worldwide, with the most dramatic increase being seen with respect to esophageal adenocarcinoma...
- Effect of paraesophageal hernia repair on pulmonary functionDonald E Low
Section of General Thoracic Surgery, Virginia Mason Medical Center, Seattle, Washington 98101, USA
Ann Thorac Surg 74:333-7; discussion 337. 2002..We have noted that patients complaining of dyspnea prior to paraesophageal hernia repair often noted significant improvement following surgery...
- Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomyDrew B Schembre
Division of Gastroenterology, Virginia Mason Medical Center, Seattle, Washington 98101, USA
Gastrointest Endosc 67:595-601. 2008..Endoscopic therapies for early neoplasia in Barrett's esophagus may be a viable alternative to esophagectomy...
- Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancerRobert J Moraca
Section of General Thoracic Surgery, Virginia Mason Medical Center, Seattle, Wash 98101, USA
Arch Surg 141:545-9; discussion 549-51. 2006..This study provides a critical assessment of outcomes and health-related quality of life (HRQL) after esophagectomy for HGD and IMC...
- Partially versus fully covered self-expanding metal stents for benign and malignant esophageal conditions: a single center experienceGülseren Seven
The Digestive Disease Institute at Virginia Mason, Virginia Mason Medical Center, 1100 9th Ave, Mail Stop C3 GAS, PO Box 900, Seattle, WA 98101, USA
Surg Endosc 27:2185-92. 2013..We aimed to evaluate the outcome of PCSEMS and FCSEMS in patients with both benign and malignant esophageal diseases...
- Near-total esophagectomy: the influence of standardized multimodal management and intraoperative fluid restrictionJoseph M Neal
Department of Anesthesiology, Virginia Mason Medical Center, Seattle, WA, USA
Reg Anesth Pain Med 28:328-34. 2003..Esophagectomy can be associated with high morbidity and mortality. We present our experience managing these patients using a standardized multimodal approach that emphasizes intraoperative fluid restriction and early extubation...
- Assessment of criteria and clinical significance of circumferential resection margins in esophageal cancerMatthew Deeter
Department of Thoracic Surgery and Pathology, Virginia Mason Medical Center, Seattle, WA 98111, USA
Arch Surg 144:618-24. 2009..To assess the clinical significance of circumferential resection margins according to current criteria of the College of American Pathologists (CAP) and the Royal College of Pathology (RCP) in esophageal and esophagogastric cancer...
- Use of self-expandable metallic stents in benign GI diseasesRaju P Wadhwa
Section of Gastroenterology, Virginia Mason Medical Center, Seattle, Washington 98101, USA
Gastrointest Endosc 58:207-12. 2003..There are few data available regarding long-term complications and outcomes with use of self-expandable metallic stents in benign disease and virtually none regarding attempted removal once the acute problem is resolved...
- West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral OntarioCaitlin Pepperell
Divisions of Infectious Diseases, University of Toronto, Toronto, Ont, Canada
CMAJ 168:1399-405. 2003..We encountered a number of seriously ill patients at our hospitals. In this article we document the clinical characteristics of these cases...
- Severe acute respiratory syndrome (SARS): a year in reviewDanuta M Skowronski
University of British Columbia Center for Disease Control, Vancouver, British Columbia, Canada V5Z 4R4
Annu Rev Med 56:357-81. 2005..This review synthesizes lessons learned from this remarkable achievement. These lessons can be applied to re-emergence of SARS or to the next pandemic threat to arise...
- Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, CanadaMatthew P Muller
Department of Microbiology, Mount Sinai Hospital, 600 University Ave, Toronto, Ontario, Canada M5G 1X5
Arch Intern Med 163:467-72. 2003..During the past 2 decades there has been a resurgence of invasive GAS infection, but no large study of GAS pneumonia has been performed...
- Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak?Michael A Gardam
Infection Prevention and Control Unit, Toronto General Hospital, Toronto, Ontario, Canada M5G 2C4
J Infect Dis 186:1754-60. 2002..The annual cost of a surveillance program was calculated at Canadian $1,130,184.44. Thus, the routine and costly use of MDRE surveillance and isolation precautions are not warranted in the absence of a clonal outbreak in this population...
- Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approachAnna Norrby-Teglund
Centre for Infectious Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
Scand J Infect Dis 37:166-72. 2005....
- Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin dropsW Bruce Jackson
University of Ottawa Eye Institute, Ottawa Hospital, Ont
Can J Ophthalmol 37:228-37; discussion 237. 2002..3% tobramycin ophthalmic solution (Tobrex) in the treatment of suspected bacterial conjunctivitis...
- Spontaneous intramural rupture of the esophagus: clinical presentation and endoscopic findingsMichael Gluck
Gastroenterology, Virginia Mason Medical Center, Seattle, Washington 98111, USA
Gastrointest Endosc 56:134-6. 2002